Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Rating $74.90 -0.55 (-0.73%) Closing price 04:10 PM EasternExtended Trading$74.90 -0.01 (-0.01%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GSSC Aggregate RatingModerate Buy 2.69Holdings in GSSC have an aggregate rating of Moderate Buy based on 219 analyst ratings issued in the past year covering 24 companies (7.2% of the portfolio).GSSC Aggregate Price Target$74.90High Prediction$74.90Average Prediction$74.90Low Prediction$74.90Holdings in GSSC have an aggregate price target of $74.90 and a range of $74.90 to $74.90 covering 24 companies (7.2% of the portfolio).GSSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 GSSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings0.45%CRDOCredo Technology Group$151.15+1.5%4.061 of 5 stars3.06$128.55 -15.0%16Analyst ForecastInsider TradeGap Down0.42%IESCIES$395.88-1.0%1.8226 of 5 stars3.0010.39%CVLTCommVault Systems$176.52-0.7%4.675 of 5 stars2.64$208.33 18.0%11Analyst Forecast0.33%HIMSHims & Hers Health$58.13-0.1%3.3629 of 5 stars1.93$38.92 -33.1%14Trending NewsInsider Trade0.32%WTSWatts Water Technologies$273.32-2.5%4.5019 of 5 stars2.33$253.80 -7.1%60.32%ALKSAlkermes$31.38-0.4%4.4045 of 5 stars2.93$42.00 33.8%140.31%INODInnodata$91.73-1.6%1.3796 of 5 stars2.80$63.00 -31.3%50.31%PRIMPrimoris Services$137.44-1.3%4.5531 of 5 stars2.77$125.17 -8.9%13Analyst Forecast0.30%STRLSterling Infrastructure$355.53-3.1%1.8534 of 5 stars3.25$355.00 -0.1%4Analyst Forecast0.28%RMBSRambus$98.72-0.7%3.291 of 5 stars3.00$96.63 -2.1%11Analyst Downgrade0.28%ENSGThe Ensign Group$175.93-0.2%4.5892 of 5 stars2.86$172.67 -1.9%7Analyst Forecast0.28%IDCCInterDigital$348.32-0.6%2.0102 of 5 stars2.75$345.00 -1.0%4Insider Trade0.28%JXNJackson Financial$99.75-1.1%2.4416 of 5 stars2.00$109.20 9.5%7Analyst Forecast0.28%LRNStride$144.85+0.0%2.6474 of 5 stars2.71$146.40 1.1%7Positive NewsAnalyst Forecast0.28%PJTPJT Partners$172.52+0.9%3.3083 of 5 stars2.14$193.00 11.9%7Analyst Forecast0.27%TBBKBancorp$76.85+0.3%2.9553 of 5 stars2.88$62.00 -19.3%8Analyst Downgrade0.27%ENVAEnova International$107.80-0.4%2.9815 of 5 stars3.00$111.00 3.0%8Analyst Forecast0.26%FNFabrinet$382.83-0.2%2.4643 of 5 stars2.56$323.17 -15.6%9Analyst Forecast0.26%UNFIUnited Natural Foods$42.47-0.1%3.5965 of 5 stars2.31$36.00 -15.2%13Positive News0.26%UMBFUMB Financial$118.67-0.3%4.9517 of 5 stars2.77$137.40 15.8%13Analyst Forecast0.26%IONQIonQ$77.67+4.5%1.3857 of 5 stars2.36$58.33 -24.9%14Trending NewsAnalyst Downgrade0.25%TGTXTG Therapeutics$34.97-2.2%4.4269 of 5 stars2.67$49.00 40.1%6Positive NewsAnalyst ForecastAnalyst Revision0.25%SUPNSupernus Pharmaceuticals$49.51+3.1%4.0816 of 5 stars3.00$64.00 29.3%5Analyst ForecastGap UpHigh Trading Volume0.25%PTCTPTC Therapeutics$66.01+2.4%3.3828 of 5 stars2.50$69.00 4.5%16Analyst ForecastInsider Trade This page (NYSEARCA:GSSC) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
